Skip to content

Salvia divinorum: all studies

Page 38 of 41: studies 371 to 380 of 408, newest first. Back to the salvia divinorum overview

Research

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.

Journal of Psychopharmacology July 1, 2012 Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura et al. 99 citations

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a psychoactive analogue of mescaline that is becoming increasingly popular as a rave and club drug. We investigated its presence in the illicit drug market in Spain, its pattern of use and profile of subjective effects. Drug material was analysed for 2C-B and information on pattern of use and subjective effects was obtained from recreational users....

DOI: 10.1177/0269881111431752 (opens in new tab) Full text (opens in new tab) 2c-b drug Synthetic drug 2c-b 2c-b substance Drug trends +18

Quantitative Analysis of Narrative Reports of Psychedelic Drugs

arXiv Preprint Archive June 1, 2012 Jeremy Coyle, David E. Presti, Matthew J. Baggott preprint

Background: Psychedelic drugs facilitate profound changes in consciousness and have potential to provide insights into the nature of human mental processes and their relation to brain physiology. Yet published scientific literature reflects a very limited understanding of the effects of these drugs, especially for newer synthetic compounds. The number of clinical trials and range of drugs...

Full text (opens in new tab) Q-bio.qm Psychedelics Natural language processing Consciousness research

Semisynthetic neoclerodanes as kappa opioid receptor probes.

Bioorganic & Medicinal Chemistry May 1, 2012 Kimberly M Lovell, Tamara Vasiljevik, Juan J Araya et al. 35 citations

Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as...

Design and synthesis of natural product-based ligands with high affinity to the kappa-opioid receptor

Planta Medica August 1, 2011 JK Zjawiony, PR Polepally, B.l. Roth et al. 10 citations

Psychoactive natural products play an important role in the discovery and development of new drugs for the treatment of central nervous system (CNS) disorders. Our studies are focusing on identification of plant metabolites responsible for CNS activity and designing new ligands with high affinity to CNS receptors. Salvinorin A, the most potent naturally occurring hallucinogen isolated from the...

Caves and the Ancient Greek Mind: Descending Underground in the Search for Ultimate Truth (review)

The Classical World June 1, 2011 Suzanne Lye

Reviewed by: Caves and the Ancient Greek Mind: Descending Underground in the Search for Ultimate Truth Suzanne Lye Yulia Ustinova . Caves and the Ancient Greek Mind: Descending Underground in the Search for Ultimate Truth. Oxford: Oxford University Press, 2009. Pp. x, 315. $95.00. ISBN 978-0-19-954856-9. Yulia Ustinova provides a study of the use of caves and underground chambers in ancient...

“Legal Highs” – New Players in the Old Drama

Current Drug Abuse Reviews June 1, 2011 Jolanta B. Zawilska 61 citations

Recently, a new class of “designer drugs” has emerged on the drug use market, known as “legal highs” or “herbal highs”. They include a wide range of products, from natural plant-originated substances to synthetic compounds, that can be purchased both online and from high street retailers. “Legal highs” mimic psychoactive effects of illicit drugs of abuse. However, they are claimed to consist of...

"Legal highs" on the net-Evaluation of UK-based Websites, products and product information.

Forensic Science International March 20, 2011 Martin M Schmidt, Akhilesh Sharma, Fabrizio Schifano et al. 198 citations

A vast array of substances are marketed as "legal highs" in the UK. These products are mainly marketed online and are packaged and produced to mimic illicit drugs. Little is known about the full range of products available at present and no studies have evaluated the product information provided to consumers. AIMS & HYPOTHESIS: To describe the available legal high products marketed by UK-based...

DOI: 10.1016/j.forsciint.2010.06.030 (opens in new tab) Full text (opens in new tab) Legal highs New psychoactive substances Nps Designer drugs +20

Absorption, Distribution, Metabolism and Excretion Pharmacogenomics of Drugs of Abuse

Pharmacogenomics February 1, 2011 Markus R Meyer, Hans H Maurer 107 citations

Pharmacologic and toxic effects of xenobiotics, such as drugs of abuse, depend on the genotype and phenotype of an individual, and conversely on the isoenzymes involved in their metabolism and transport. The current knowledge of such isoenzymes of frequently abused therapeutics such as opioids (oxycodone, hydrocodone, methadone, fentanyl, buprenorphine, tramadol, heroin, morphine and codeine),...

DOI: 10.2217/pgs.10.171 (opens in new tab) Pharmacology Alfentanil Hydrocodone Oxycodone +6

Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter

2011 Bridget Simonson 1 citation

Classic kappa opioid receptor (KOPr) agonists have shown anti-addictive properties in rat models of addiction (Heidbreder et al. 1998; Schenk et al. 1999; Sun et al. 2010), and this has been shown to be partially through modulation of dopamine and serotonin in the synapse (Thompson et al. 2000; Zhang et al. 2004; Zakharova et al. 2008a). However, they have side effects such as depression and...

Behavioural Pharmacology of Novel Kappa Opioid Compounds

Figshare 2011 Aashish S Morani 1 citation

Rationale: Kappa opioid receptor (KOPr) activation by traditional agonists has been shown to produce anti-addiction behaviours. However, adverse effects such as sedation, aversion and depression have limited their clinical development. Recently, salvinorin A (Sal A), an active component of the plant Salvia divinorum was shown to be a potent and selective KOPr agonist. Sal A has a short duration...